BCIQ Profiles

Company Profile Report

AQS1301: Clinical trial started

Aequus began a Canadian proof-of-concept (POC) trial to evaluate once-weekly transdermal AQS1301

Read the full 121 word article

How to gain access

Continue reading with a
two-week free trial.